Predictive Value of Early MRI Measures for Long-Term Disease Activity in Patients with Relapsing-Remitting Multiple Sclerosis Receiving IFN β-1a SC tiw or IFN β-1a IM qw: Post Hoc Analyses of the EVIDENCE Study

被引：0
|
作者：
Coyle, Patricia [3 ]
Freedman, Mark [5 ,6 ]
Dangond, Fernando [1 ]
Fang, Juanzhi [2 ]
Reder, Anthony [4 ]
机构：
[1] EMD Serono Inc, Billerica, MA USA
[2] EMD Serono Inc, Rockland, MA USA
[3] SUNY Stony Brook, Med Ctr, Stony Brook, NY 11794 USA
[4] Univ Chicago, Chicago, IL 60637 USA
[5] Univ Ottawa, Ottawa, ON, Canada
[6] Ottawa Hosp, Res Inst, Ottawa, ON, Canada
来源：
NEUROLOGY | 2016年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P6.189
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Predictive value of early MRI measures for long-term disease activity in patients with relapsing-remitting multiple sclerosis receiving IFN β-1a SC tiw or IFN β-1a IM qw: post hoc analyses of the EVIDENCE study
    Coyle, P. K.
    Freedman, M. S.
    Dangond, F.
    Fang, J.
    Reder, A. T.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 594 - 595
  • [2] Early MRI Lesions as a predictor for longer term disease activity among patients with RRMS receiving IFN β-1a SC tiw or IFN β-1a IM qw: post hoc analyses of EVIDENCE
    Coyle, P. K.
    Freedman, M. S.
    Zhang, H.
    Dangond, F.
    Reder, A. T.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 803 - 803
  • [3] MRI Frequency and No Evidence of Disease Activity Status Among Patients with RRMS Receiving IFN β-1a SC tiw or IFN β-1a IM qw: Post Hoc Analyses of EVIDENCE
    Reder, Anthony
    Freedman, Mark
    Fang, Juanzhi
    Dangond, Fernando
    Coyle, Patricia
    NEUROLOGY, 2016, 86
  • [4] Development of neutralizing antibodies in patients with relapsing-remitting multiple sclerosis treated with IFN-β1a
    Antonelli, G
    Bagnato, F
    Pozzilli, C
    Simeoni, E
    Bastianelli, S
    Currenti, M
    De Pisa, F
    Fieschi, C
    Gasperini, C
    Salvetti, M
    Dianzani, F
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1998, 18 (05): : 345 - 350
  • [5] fMRI changes in relapsing-remitting multiple sclerosis patients complaining of fatigue after IFNβ-1A injection
    Rocca, Maria A.
    Agosta, Federica
    Colombo, Bruno
    Mezzapesa, Domenico M.
    Falini, Andrea
    Comi, Giancarlo
    Filippi, Massimo
    HUMAN BRAIN MAPPING, 2007, 28 (05) : 373 - 382
  • [6] Clinical and MRI efficacy of sc IFN β-1a tiw in patients with relapsing MS appearing to transition to secondary progressive MS: post hoc analyses of PRISMS and SPECTRIMS
    Mark S. Freedman
    Staley Brod
    Barry A. Singer
    Bruce A. Cohen
    Brooke Hayward
    Fernando Dangond
    Patricia K. Coyle
    Journal of Neurology, 2020, 267 : 64 - 75
  • [7] Clinical and MRI efficacy of sc IFN β-1a tiw in patients with relapsing MS appearing to transition to secondary progressive MS: post hoc analyses of PRISMS and SPECTRIMS
    Freedman, Mark S.
    Brod, Staley
    Singer, Barry A.
    Cohen, Bruce A.
    Hayward, Brooke
    Dangond, Fernando
    Coyle, Patricia K.
    JOURNAL OF NEUROLOGY, 2020, 267 (01) : 64 - 75
  • [8] Long-term benefits of early and high douses of interferon β-1a treatment in relapsing-remitting multiple sclerosis
    Chofflon, M
    Ben-Amor, AF
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2002, 104 (03) : 244 - 248
  • [9] IFN-β1a may increase serum levels of TIMP-1 in patients with relapsing-remitting multiple sclerosis
    Waubant, E
    Gee, L
    Miller, K
    Stabler, G
    Goodkin, D
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2001, 21 (03): : 181 - 185
  • [10] Immunomodulatory effects of IFN-β1a treatment alone or associated with pentoxifylline in patients with relapsing-remitting multiple sclerosis (RRMS)
    Di Pede, P
    Visintini, D
    Telera, A
    Cucurachi, L
    Campanini, C
    Immovilli, P
    Vescovini, R
    Sansoni, P
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2005, 25 (08): : 485 - 489
12345